Literature DB >> 17347126

HIV incidence, retention, and changes of high-risk behaviors among rural injection drug users in Guangxi, China.

Liu Wei1, Jie Chen, Michelle Rodolph, Geetha Beauchamp, Ben Mâsse, Rongjian Li, Shaoping Wang, Yuhua Ruan, Shenghan Lai, Li Zhang, Feng Zhou, Scott M Rose, Thomas Perdue, Shenghan Lai, Yiming Shao, J Brooks Jackson.   

Abstract

BACKGROUND: A prospective observational study of HIV seroincidence among high-risk injection drug users (IDU) was carried out in Guangxi, China. The primary objectives of this study were (1) to estimate HIV seroincidence (2) to estimate participant retention rate and (3) to evaluate changes in drug use and sexual behavior over a one year period.
METHODS: Five hundred HIV seronegative IDU were enrolled. HIV-1 incidence and retention rates were analyzed as a function of sociodemographic, behavioral, and recruitment variables. Changes in drug use and sexual behavior were analyzed at the baseline, 6-month and 12-month follow- up visits.
RESULTS: At 12 months of follow-up, the HIV-1 incidence rate was 3.1 per 100 person years, [95% CI: (1.6%; 5.2%)] and participant retention rate was 87%. Reported changes in high-risk behaviors over 12-months included significant decreases in the frequency of heroin injection, in direct or indirect sharing of injection equipment, and in the number of sexual partners.
CONCLUSIONS: HIV incidence is high among IDU in Guangxi, China despite a self-reported decrease in some high risk behaviors over the course of the study.

Entities:  

Mesh:

Year:  2006        PMID: 17347126     DOI: 10.1300/j465v27n04_07

Source DB:  PubMed          Journal:  Subst Abus        ISSN: 0889-7077            Impact factor:   3.716


  13 in total

1.  Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058.

Authors:  David S Metzger; Deborah Donnell; David D Celentano; J Brooks Jackson; Yiming Shao; Apinun Aramrattana; Liu Wei; Liping Fu; Jun Ma; Gregory M Lucas; Marek Chawarski; Yuhua Ruan; Paul Richardson; Katherine Shin; Ray Y Chen; Jeremy Sugarman; Bonnie J Dye; Scott M Rose; Geetha Beauchamp; David N Burns
Journal:  J Acquir Immune Defic Syndr       Date:  2015-04-15       Impact factor: 3.731

2.  Mortality and HIV transmission among male Vietnamese injection drug users.

Authors:  Vu Minh Quan; Nguyen Le Minh; Tran Viet Ha; Nguyen Phuong Ngoc; Pham The Vu; David D Celentano; Tran Thi Mo; Vivian F Go
Journal:  Addiction       Date:  2010-11-04       Impact factor: 6.526

3.  Phase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B'/C candidate vaccine.

Authors:  Sandhya Vasan; Sarah J Schlesinger; Zhiwei Chen; Arlene Hurley; Angela Lombardo; Soe Than; Phumla Adesanya; Catherine Bunce; Mark Boaz; Rosanne Boyle; Eddy Sayeed; Lorna Clark; Daniel Dugin; Mar Boente-Carrera; Claudia Schmidt; Qing Fang; Yaoxing Huang; Gerasimos J Zaharatos; David F Gardiner; Marina Caskey; Laura Seamons; Martin Ho; Len Dally; Carol Smith; Josephine Cox; Dilbinder Gill; Jill Gilmour; Michael C Keefer; Patricia Fast; David D Ho
Journal:  PLoS One       Date:  2010-01-25       Impact factor: 3.240

4.  Phase 1 safety and immunogenicity evaluation of ADVAX, a multigenic, DNA-based clade C/B' HIV-1 candidate vaccine.

Authors:  Sandhya Vasan; Sarah J Schlesinger; Yaoxing Huang; Arlene Hurley; Angela Lombardo; Zhiwei Chen; Soe Than; Phumla Adesanya; Catherine Bunce; Mark Boaz; Rosanne Boyle; Eddy Sayeed; Lorna Clark; Daniel Dugin; Claudia Schmidt; Yang Song; Laura Seamons; Len Dally; Martin Ho; Carol Smith; Martin Markowitz; Josephine Cox; Dilbinder K Gill; Jill Gilmour; Michael C Keefer; Patricia Fast; David D Ho
Journal:  PLoS One       Date:  2010-01-25       Impact factor: 3.240

5.  Willingness of Chinese injection drug users to participate in HIV vaccine trials.

Authors:  Lu Yin; Yuanzhi Zhang; Han-Zhu Qian; Baoling Rui; Lijiang Zhang; Junling Zhu; Yongsheng Guan; Yunxia Wang; Qingchun Li; Yuhua Ruan; Yiming Shao
Journal:  Vaccine       Date:  2007-12-26       Impact factor: 3.641

6.  HIV incidence among men who have sex with men in Beijing: a prospective cohort study.

Authors:  Dongliang Li; Shuming Li; Yingjie Liu; Yanjie Gao; Mingrun Yu; Xueying Yang; Qingchun Li; Shulin Jiang; Zhenhai Zhou; Zheng Zhang; Li Yan; Guiyan Jiang; Dong Xiao; Stephen W Pan; Fengji Luo; Yuhua Ruan; Yiming Shao
Journal:  BMJ Open       Date:  2012-11-19       Impact factor: 2.692

7.  HIV-1 Treatment-as-Prevention: A Cohort Study Analysis of Serodiscordant Couples in Rural Southwest China.

Authors:  Zhenzhu Tang; Guanghua Lan; Ying Qing Chen; Qiuying Zhu; Xiaoyi Yang; Zhiyong Shen; Yi Chen; Heng Zhang; Wei Kan; Hui Xing; Yuhua Ruan; Yiming Shao
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

8.  Research fatigue among injecting drug users in Karachi, Pakistan.

Authors:  Aysha Zahidie; Arshad Altaf; Adeel Ahsan; Tanzil Jamali
Journal:  Harm Reduct J       Date:  2013-06-11

9.  Predictors of HIV infection and prevalence for syphilis infection among injection drug users in China: community-based surveys along major drug trafficking routes.

Authors:  Yujiang Jia; Fan Lu; Gang Zeng; Xinhua Sun; Yan Xiao; Lin Lu; Wei Liu; Mingjian Ni; Shuquan Qu; Chunmei Li; Jianbo Liu; Pingsheng Wu; Sten H Vermund
Journal:  Harm Reduct J       Date:  2008-08-25

10.  Do community-based strategies reduce HIV risk among people who inject drugs in China? A quasi-experimental study in Yunnan and Guangxi provinces.

Authors:  Kai Wang; Hongyun Fu; Kim Longfield; Shilpa Modi; Gary Mundy; Rebecca Firestone
Journal:  Harm Reduct J       Date:  2014-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.